Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection

References

• Hung YP, Lee JC, Lin HJ, Liu HC, Wu YH, Tsai PJ, Ko WC. Clinical impact of Clostridium difficile colonization. J Microbiol, Immunol Infect. 2015;48(3):241–20. doi:10.1016/j.jmii.2014.04.011.
   PubMedGoogle Scholar
• Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517(7533):205–208. doi:10.1038/nature13828.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46(Suppl s1):S12–18. doi:10.1086/521863.
   PubMedGoogle Scholar
• Singh H, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN. Higher incidence of Clostridium difficile infection among individuals with inflammatory bowel disease. Gastroenterology. 2017;153(2):430–438.e432. doi:10.1053/j.gastro.2017.04.044.
   PubMed Web of Science ®Google Scholar
• Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G. Clostridium difficile infection: review. Eur J Clin Microbiol. 2019;38(7):1211–1221. doi:10.1007/s10096-019-03539-6.
   Google Scholar
• Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834. doi:10.1056/NEJMoa1408913.
   PubMed Web of Science ®Google Scholar
• Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. Jama. 2015;313(4):398–408. doi:10.1001/jama.2014.17103.
   PubMed Web of Science ®Google Scholar
• Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, et al. SER-109, an oral microbiome therapy for recurrent clostridioides difficile infection. N Engl J Med. 2022;386(3):220–229. doi:10.1056/NEJMoa2106516.
   PubMed Web of Science ®Google Scholar
• Leffler DA, Lamont JT, Longo DL. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–1548. doi:10.1056/NEJMra1403772.
   PubMed Web of Science ®Google Scholar
• Buckley AM, Moura IB, Wilcox MH. The potential of microbiome replacement therapies for Clostridium difficile infection. Curr Opin Gastroenterol. 2022;38(1):1–6. doi:10.1097/MOG.0000000000000800.
   PubMed Web of Science ®Google Scholar
• Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on fecal microbiota transplantation 2015: Indications, methodologies, mechanisms, and outlook. Gastroenterology. 2015;149(1):223–237. doi:10.1053/j.gastro.2015.05.008.
   PubMed Web of Science ®Google Scholar
• Li YT, Cai HF, Wang ZH, Xu J, Fang JY. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther. 2016;43(4):445–457. doi:10.1111/apt.13492.
   PubMed Web of Science ®Google Scholar
• Haddad NS, Nozick S, Kim G, Ohanian S, Kraft CS, Rebolledo PA, Wang Y, Wu H, Bressler A, Le SNT, et al. Detection of newly secreted antibodies predicts nonrecurrence in primary Clostridioides difficile infection. J Clin Microbiol. 2022;60(3):e0220121. doi:10.1128/jcm.02201-21.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen Q, Kelly CR, Kassam Z, Qin H, Li N, Tian H, Yang B, Zhao D, Ye C, et al. Donor screening for fecal microbiota transplantation in China: evaluation of 8483 candidates. Gastroenterology. 2022;162(3):966–968.e963. doi:10.1053/j.gastro.2021.11.004.
   PubMed Web of Science ®Google Scholar
• Tian H, Zhang S, Qin H, Li N, Chen Q. Long-term safety of faecal microbiota transplantation for gastrointestinal diseases in China. Lancet Gastroenterol Hepatol. 2022;7(8):702–703. doi:10.1016/S2468-1253(22)00170-4.
   PubMed Web of Science ®Google Scholar
• Alliance CMTI. MCoSPM A: Chinese experts consensus on clinical practice of the selection and establishment of fecal microbiota transplantation delivery routes. Chinese J Gastrointestinal Surg. 2020;23:14–20.
   Google Scholar
• D’Haens GR, Jobin C. Fecal microbial transplantation for diseases beyond recurrent clostridium difficile infection. Gastroenterology. 2019;157(3):624–636. doi:10.1053/j.gastro.2019.04.053.
   PubMed Web of Science ®Google Scholar
• He R, Li P, Wang J, Cui B, Zhang F, Zhao F. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation. Gut Microbes. 2022;14(1):2100197. doi:10.1080/19490976.2022.2100197.
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180. doi:10.1038/nature09944.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Punčochář M, Karcher N, Porcari S, Armanini F, Asnicar F, Beghini F, Blanco-Míguez A, Cumbo F, Manghi P, et al. Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases. Nat Med. 2022;28(9):1913–1923. doi:10.1038/s41591-022-01964-3.
   PubMed Web of Science ®Google Scholar
• Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastro Hepat. 2021;18(1):67–80. doi:10.1038/s41575-020-0350-4.
   PubMed Web of Science ®Google Scholar
• Mehta SR, Yen EF. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy. Transl Res. 2021;230:197–207. doi:10.1016/j.trsl.2020.11.013.
   PubMed Web of Science ®Google Scholar
• Wei S, Bahl MI, Baunwall SMD, Dahlerup JF, Hvas CL, Licht TR. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent Clostridioides difficile infection. Gut Microbes. 2022;14(1):2084306. doi:10.1080/19490976.2022.2084306.
   PubMed Web of Science ®Google Scholar
• Amrane S, Hocquart M, Afouda P, Kuete E, Pham TP, Dione N, Ngom II, Valles C, Bachar D, Raoult D, et al. Metagenomic and culturomic analysis of gut microbiota dysbiosis during Clostridium difficile infection. Sci Rep. 2019;9(1):12807. doi:10.1038/s41598-019-49189-8.
   PubMedGoogle Scholar
• Mintz M, Khair S, Grewal S, LaComb JF, Park J, Channer B, Rajapakse R, Bucobo JC, Buscaglia JM, Monzur F, et al. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis. PLoS One. 2018;13(1):e0190997. doi:10.1371/journal.pone.0190997.
   PubMed Web of Science ®Google Scholar
• Azimirad M, Jo Y, Kim MS, Jeong M, Shahrokh S, Asadzadeh Aghdaei H, Zali MR, Lee S, Yadegar A, Shin JH. Alterations and prediction of functional profiles of gut microbiota after fecal microbiota transplantation for Iranian recurrent clostridioides difficile infection with underlying inflammatory bowel disease: A pilot study. J Inflamm Res. 2022;15:105–116. doi:10.2147/JIR.S338212.
   PubMed Web of Science ®Google Scholar
• Ferreyra JA, Wu KJ, Hryckowian AJ, Bouley DM, Weimer BC, Sonnenburg JL. Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance. Cell Host & Microbe. 2014;16(6):770–777. doi:10.1016/j.chom.2014.11.003.
   PubMed Web of Science ®Google Scholar
• Wan J, Zhang Y, He W, Tian Z, Lin J, Liu Z, Li Y, Chen M, Han S, Liang J, et al. Gut microbiota and metabolite changes in patients with Ulcerative colitis and clostridioides difficile infection. Front Microbiol. 2022;13:802823. doi:10.3389/fmicb.2022.802823.
   PubMed Web of Science ®Google Scholar
• Zhu L, Xu LZ, Zhao S, Shen ZF, Shen H, Zhan LB. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol. 2020;104(12):5449–5460. doi:10.1007/s00253-020-10527-w.
   PubMed Web of Science ®Google Scholar
• Ankersen DV, Weimers P, Marker D, Johannesen T, Iversen S, Lilje B, Kristoffersen AB, Saboori S, Paridaens K, Skytt Andersen P, et al. eHealth: disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis. Scand J Gastroenterol. 2020;55(11):1291–1300. doi:10.1080/00365521.2020.1829031.
   PubMed Web of Science ®Google Scholar
• Xu H, Yang J, Gao W, Li L, Li P, Zhang L, Gong YN, Peng X, Xi JJ, Chen S, et al. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature. 2014;513(7517):237–241. doi:10.1038/nature13449.
   PubMed Web of Science ®Google Scholar
• Fachi JL, Felipe JS, Pral LP, da Silva BK, Corrêa RO, de Andrade MCP, da Fonseca DM, Basso PJ, Câmara NOS, de Sales ESÉ, et al. Butyrate protects mice from clostridium difficile-induced colitis through an HIF-1-dependent mechanism. Cell Rep. 2019;27(3):750–761.e7. doi:10.1016/j.celrep.2019.03.054.
   PubMed Web of Science ®Google Scholar
• Shen Z, Zhu C, Quan Y, Yang J, Yuan W, Yang Z, Wu S, Luo W, Tan B, Wang X. Insights into Roseburia intestinalis which alleviates experimental colitis pathology by inducing anti-inflammatory responses. J Gastroen Hepatol. 2018;33(10):1751–1760. doi:10.1111/jgh.14144.
   PubMed Web of Science ®Google Scholar
• Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51(9):2884–2892. doi:10.1128/JCM.00845-13.
   PubMed Web of Science ®Google Scholar
• Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL. Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model. Nature Microbiol. 2018;3(6):662–669. doi:10.1038/s41564-018-0150-6.
   PubMed Web of Science ®Google Scholar
• Liu C, Ng SK, Ding Y, Lin Y, Liu W, Wong SH, Sung JJ, Yu J. Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis. Oncogene. 2022;41(28):3599–3610. doi:10.1038/s41388-022-02377-9.
   PubMed Web of Science ®Google Scholar
• Nagata N, Nishijima S, Kojima Y, Hisada Y, Imbe K, Miyoshi-Akiyama T, Suda W, Kimura M, Aoki R, Sekine K, et al. Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study. Gastroenterology. 2022;163(1):222–238. doi:10.1053/j.gastro.2022.03.054.
   PubMed Web of Science ®Google Scholar
• Dawkins JJ, Allegretti JR, Gibson TE, McClure E, Delaney M, Bry L, Gerber GK. Gut metabolites predict Clostridioides difficile recurrence. Microbiome. 2022;10(1):87. doi:10.1186/s40168-022-01284-1.
   PubMed Web of Science ®Google Scholar
• Pakpour S, Bhanvadia A, Zhu R, Amarnani A, Gibbons SM, Gurry T, Alm EJ, Martello LA. Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment. Microbiome. 2017;5(1):148. doi:10.1186/s40168-017-0368-1.
   PubMedGoogle Scholar
• Coker JK, Moyne O, Rodionov DA, Zengler K. Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health. Gut Microbes. 2021;13(1):1–18. doi:10.1080/19490976.2020.1869502.
   PubMed Web of Science ®Google Scholar
• Smillie CS, Sauk J, Gevers D, Friedman J, Sung J, Youngster I, Hohmann EL, Staley C, Khoruts A, Sadowsky MJ, et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host & Microbe. 2018;23(2):229–240.e225. doi:10.1016/j.chom.2018.01.003.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yin A, Li H, Wang R, Wu G, Shen J, Zhang M, Wang L, Hou Y, Ouyang H, et al. Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine. 2015;2(8):968–984. doi:10.1016/j.ebiom.2015.07.007.
   PubMed Web of Science ®Google Scholar
• Yang J, Li Y, Wen Z, Liu W, Meng L, Huang H. Oscillospira - a candidate for the next-generation probiotics. Gut Microbes. 2021;13(1):1987783. doi:10.1080/19490976.2021.1987783.
   PubMed Web of Science ®Google Scholar
• Parthasarathy G, Chen J, Chen X, Chia N, O’Connor HM, Wolf PG, Gaskins HR, Bharucha AE. Relationship between microbiota of the Colonic Mucosa vs Feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology. 2016;150(2):367–379.e361. doi:10.1053/j.gastro.2015.10.005.
   PubMed Web of Science ®Google Scholar
• Zhao S, Lieberman TD, Poyet M, Kauffman KM, Gibbons SM, Groussin M, Xavier RJ, Alm EJ. Adaptive evolution within gut microbiomes of healthy people. Cell Host Microbe. 2019;25(5):656–667.e658. doi:10.1016/j.chom.2019.03.007.
   PubMed Web of Science ®Google Scholar
• Priya S, Blekhman R. Population dynamics of the human gut microbiome: change is the only constant. Genome Biol. 2019;20(1):150. doi:10.1186/s13059-019-1775-3.
   PubMedGoogle Scholar
• Martinson JNV, Pinkham NV, Peters GW, Cho H, Heng J, Rauch M, Broadaway SC, Walk ST. Rethinking gut microbiome residency and the Enterobacteriaceae in healthy human adults. Isme J. 2019;13(9):2306–2318. doi:10.1038/s41396-019-0435-7.
   PubMed Web of Science ®Google Scholar
• Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature. 2013;501(7467):426–429. doi:10.1038/nature12447.
   PubMed Web of Science ®Google Scholar
• Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332(6032):974–977. doi:10.1126/science.1206095.
   PubMed Web of Science ®Google Scholar
• Donaldson GP, Ladinsky MS, Yu KB, Sanders JG, Yoo BB, Chou WC, Conner ME, Earl AM, Knight R, Bjorkman PJ, et al. Gut microbiota utilize immunoglobulin a for mucosal colonization. Science. 2018;360(6390):795–800. doi:10.1126/science.aaq0926.
   PubMed Web of Science ®Google Scholar
• Luis AS, Jin C, Pereira GV, Glowacki RWP, Gugel SR, Singh S, Byrne DP, Pudlo NA, London JA, Baslé A, et al. A single sulfatase is required to access colonic mucin by a gut bacterium. Nature. 2021;598(7880):332–337. doi:10.1038/s41586-021-03967-5.
   PubMed Web of Science ®Google Scholar
• Valles-Colomer M, Bacigalupe R, Vieira-Silva S, Suzuki S, Darzi Y, Tito RY, Yamada T, Segata N, Raes J, Falony G. Variation and transmission of the human gut microbiota across multiple familial generations. Nature Microbiol. 2022;7(1):87–96. doi:10.1038/s41564-021-01021-8.
   PubMed Web of Science ®Google Scholar
• Browne HP, Almeida A, Kumar N, Vervier K, Adoum AT, Viciani E, Dawson NJR, Forster SC, Cormie C, Goulding D, et al. Host adaptation in gut Firmicutes is associated with sporulation loss and altered transmission cycle. Genome Biol. 2021;22(1):204. doi:10.1186/s13059-021-02428-6.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262–1267. doi:10.1126/science.1223813.
   PubMed Web of Science ®Google Scholar
• Reyman M, van Houten MA, Watson RL, Chu M, Arp K, de Waal WJ, Schiering I, Plötz FB, Willems RJL, van Schaik W, et al. Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial. Nat Commun. 2022;13(1):893. doi:10.1038/s41467-022-28525-z.
   PubMed Web of Science ®Google Scholar
• Soldi S, Vasileiadis S, Lohner S, Uggeri F, Puglisi E, Molinari P, Donner E, Sieland C, Decsi T, Sailer M, et al. Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children. Benef Microbes. 2019;10(3):253–263. doi:10.3920/BM2018.0116.
   PubMed Web of Science ®Google Scholar
• Beck LC, Masi AC, Young GR, Vatanen T, Lamb CA, Smith R, Coxhead J, Butler A, Marsland BJ, Embleton ND, et al. Strain-specific impacts of probiotics are a significant driver of gut microbiome development in very preterm infants. Nature Microbiol. 2022;7(10):1525–1535. doi:10.1038/s41564-022-01213-w.
   PubMed Web of Science ®Google Scholar
• Hirano R, Sakanaka M, Yoshimi K, Sugimoto N, Eguchi S, Yamauchi Y, Nara M, Maeda S, Ami Y, Gotoh A, et al. Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile. Gut Microbes. 2021;13(1):1973835. doi:10.1080/19490976.2021.1973835.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhong H, Li Y, Shi Z, Ren H, Zhang Z, Zhou X, Tang S, Han X, Lin Y, et al. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities. Nature Aging. 2021;1(1):87–100. doi:10.1038/s43587-020-00014-2.
   PubMedGoogle Scholar
• Tuikhar N, Keisam S, Labala RK, Ramakrishnan P, Arunkumar MC, Ahmed G, Biagi E, Jeyaram K. Comparative analysis of the gut microbiota in centenarians and young adults shows a common signature across genotypically non-related populations. Mech Ageing Dev. 2019;179:23–35. doi:10.1016/j.mad.2019.02.001.
   PubMed Web of Science ®Google Scholar
• Wang D, Dong D, Wang C, Cui Y, Jiang C, Ni Q, Su T, Wang G, Mao E, Peng Y. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units. Crit Care. 2020;24(1):426. doi:10.1186/s13054-020-03119-7.
   PubMed Web of Science ®Google Scholar